?>
Plan Name | THE ALBANY MEDICAL CENTER RETIREMENT PLAN |
Plan identification number | 003 |
401k Plan Type | Defined Benefit Pension |
Plan Features/Benefits |
|
Company Name: | ALBANY MED HEALTH SYSTEM |
Employer identification number (EIN): | 141641730 |
NAIC Classification: | 622000 |
NAIC Description: | Hospitals |
Additional information about ALBANY MED HEALTH SYSTEM
Jurisdiction of Incorporation: | New York Department of State |
Incorporation Date: | 1982-10-08 |
Company Identification Number: | 797561 |
Legal Registered Office Address: |
ATTN: PRESIDENT 43 NEW SCOTLAND AVENUE ALBANY United States of America (USA) 12208 |
More information about ALBANY MED HEALTH SYSTEM
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
003 | 2022-01-01 | ||||
003 | 2021-01-01 | ||||
003 | 2020-01-01 | ||||
003 | 2019-01-01 | ||||
003 | 2018-01-01 | ||||
003 | 2017-01-01 | FRANCES S. ALBERT |
Measure | Date | Value |
---|---|---|
2022: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2022 401k membership | ||
Market value of plan assets | 2022-12-31 | 408,593,803 |
Acturial value of plan assets | 2022-12-31 | 397,012,896 |
Funding target for retired participants and beneficiaries receiving payment | 2022-12-31 | 27,210,305 |
Number of terminated vested participants | 2022-12-31 | 4,903 |
Fundng target for terminated vested participants | 2022-12-31 | 56,630,138 |
Active participant vested funding target | 2022-12-31 | 191,006,094 |
Number of active participants | 2022-12-31 | 7,778 |
Total funding liabilities for active participants | 2022-12-31 | 193,899,369 |
Total participant count | 2022-12-31 | 12,882 |
Total funding target for all participants | 2022-12-31 | 277,739,812 |
Balance at beginning of prior year after applicable adjustments | 2022-12-31 | 115,113,720 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2022-12-31 | 14,493,356 |
Amount remaining of carryover balance | 2022-12-31 | 100,620,364 |
Balance of carryovers at beginning of current year | 2022-12-31 | 107,714,100 |
Minimum required contributions for current year target normal cost | 2022-12-31 | 14,974,156 |
Total funding amount beforereflecting carryover/prefunding balances | 2022-12-31 | 3,415,172 |
Carryover balance elected to use to offset funding requirement | 2022-12-31 | 3,415,172 |
Additional cash requirement | 2022-12-31 | 0 |
Total participants, beginning-of-year | 2022-01-01 | 12,882 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 7,722 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 238 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 5,165 |
Total of all active and inactive participants | 2022-01-01 | 13,125 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 48 |
Total participants | 2022-01-01 | 13,173 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-01-01 | 381 |
2021: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2021 401k membership | ||
Market value of plan assets | 2021-12-31 | 412,582,926 |
Acturial value of plan assets | 2021-12-31 | 386,935,126 |
Funding target for retired participants and beneficiaries receiving payment | 2021-12-31 | 21,842,354 |
Number of terminated vested participants | 2021-12-31 | 4,288 |
Fundng target for terminated vested participants | 2021-12-31 | 53,832,479 |
Active participant vested funding target | 2021-12-31 | 196,951,567 |
Number of active participants | 2021-12-31 | 8,295 |
Total funding liabilities for active participants | 2021-12-31 | 199,939,396 |
Total participant count | 2021-12-31 | 12,743 |
Total funding target for all participants | 2021-12-31 | 275,614,229 |
Balance at beginning of prior year after applicable adjustments | 2021-12-31 | 113,154,507 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2021-12-31 | 9,783,710 |
Amount remaining of carryover balance | 2021-12-31 | 103,370,797 |
Present value of excess contributions | 2021-12-31 | 15,180,680 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2021-12-31 | 16,583,545 |
Balance of carryovers at beginning of current year | 2021-12-31 | 115,113,720 |
Minimum required contributions for current year target normal cost | 2021-12-31 | 14,493,356 |
Total funding amount beforereflecting carryover/prefunding balances | 2021-12-31 | 14,493,356 |
Carryover balance elected to use to offset funding requirement | 2021-12-31 | 14,493,356 |
Additional cash requirement | 2021-12-31 | 0 |
Total participants, beginning-of-year | 2021-01-01 | 12,743 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 7,696 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 198 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 4,867 |
Total of all active and inactive participants | 2021-01-01 | 12,761 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 39 |
Total participants | 2021-01-01 | 12,800 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 516 |
2020: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2020 401k membership | ||
Market value of plan assets | 2020-12-31 | 379,808,988 |
Acturial value of plan assets | 2020-12-31 | 368,422,484 |
Funding target for retired participants and beneficiaries receiving payment | 2020-12-31 | 13,819,911 |
Number of terminated vested participants | 2020-12-31 | 3,964 |
Fundng target for terminated vested participants | 2020-12-31 | 52,026,418 |
Active participant vested funding target | 2020-12-31 | 217,499,926 |
Number of active participants | 2020-12-31 | 8,267 |
Total funding liabilities for active participants | 2020-12-31 | 220,429,548 |
Total participant count | 2020-12-31 | 12,329 |
Total funding target for all participants | 2020-12-31 | 286,275,877 |
Balance at beginning of prior year after applicable adjustments | 2020-12-31 | 106,487,136 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2020-12-31 | 9,963,629 |
Amount remaining of carryover balance | 2020-12-31 | 96,523,507 |
Present value of excess contributions | 2020-12-31 | 2,635,206 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2020-12-31 | 2,780,933 |
Balance of carryovers at beginning of current year | 2020-12-31 | 113,154,507 |
Total employer contributions | 2020-12-31 | 21,375,000 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2020-12-31 | 20,305,236 |
Minimum required contributions for current year target normal cost | 2020-12-31 | 14,908,266 |
Total funding amount beforereflecting carryover/prefunding balances | 2020-12-31 | 14,908,266 |
Carryover balance elected to use to offset funding requirement | 2020-12-31 | 9,783,710 |
Additional cash requirement | 2020-12-31 | 5,124,556 |
Contributions allocatedtoward minimum required contributions for current year | 2020-12-31 | 20,305,236 |
Total participants, beginning-of-year | 2020-01-01 | 12,329 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 8,208 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 159 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 4,261 |
Total of all active and inactive participants | 2020-01-01 | 12,628 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 28 |
Total participants | 2020-01-01 | 12,656 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 389 |
2019: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2019 401k membership | ||
Market value of plan assets | 2019-12-31 | 333,772,110 |
Acturial value of plan assets | 2019-12-31 | 350,374,503 |
Funding target for retired participants and beneficiaries receiving payment | 2019-12-31 | 7,126,150 |
Number of terminated vested participants | 2019-12-31 | 3,565 |
Fundng target for terminated vested participants | 2019-12-31 | 49,598,669 |
Active participant vested funding target | 2019-12-31 | 222,189,281 |
Number of active participants | 2019-12-31 | 8,200 |
Total funding liabilities for active participants | 2019-12-31 | 226,113,944 |
Total participant count | 2019-12-31 | 11,817 |
Total funding target for all participants | 2019-12-31 | 282,838,763 |
Balance at beginning of prior year after applicable adjustments | 2019-12-31 | 114,427,104 |
Carryover balanced portion elected for use to offset prior years funding requirement | 2019-12-31 | 3,860,043 |
Amount remaining of carryover balance | 2019-12-31 | 110,567,061 |
Balance of carryovers at beginning of current year | 2019-12-31 | 106,487,136 |
Total employer contributions | 2019-12-31 | 8,375,000 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2019-12-31 | 7,862,958 |
Minimum required contributions for current year target normal cost | 2019-12-31 | 15,191,381 |
Total funding amount beforereflecting carryover/prefunding balances | 2019-12-31 | 15,191,381 |
Carryover balance elected to use to offset funding requirement | 2019-12-31 | 9,963,629 |
Additional cash requirement | 2019-12-31 | 5,227,752 |
Contributions allocatedtoward minimum required contributions for current year | 2019-12-31 | 7,862,958 |
Total participants, beginning-of-year | 2019-01-01 | 11,817 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 8,178 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 97 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 3,934 |
Total of all active and inactive participants | 2019-01-01 | 12,209 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 31 |
Total participants | 2019-01-01 | 12,240 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 396 |
2018: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2018 401k membership | ||
Market value of plan assets | 2018-12-31 | 409,799,724 |
Acturial value of plan assets | 2018-12-31 | 392,138,230 |
Funding target for retired participants and beneficiaries receiving payment | 2018-12-31 | 38,663,579 |
Number of terminated vested participants | 2018-12-31 | 3,200 |
Fundng target for terminated vested participants | 2018-12-31 | 45,802,441 |
Active participant vested funding target | 2018-12-31 | 219,079,866 |
Number of active participants | 2018-12-31 | 8,116 |
Total funding liabilities for active participants | 2018-12-31 | 223,170,529 |
Total participant count | 2018-12-31 | 11,772 |
Total funding target for all participants | 2018-12-31 | 307,636,549 |
Balance at beginning of prior year after applicable adjustments | 2018-12-31 | 100,639,493 |
Amount remaining of carryover balance | 2018-12-31 | 100,639,493 |
Present value of excess contributions | 2018-12-31 | 3,437,172 |
Total available prior years excess cotributions available at beginning of current plan year to add to prefunding balance | 2018-12-31 | 3,640,653 |
Balance of carryovers at beginning of current year | 2018-12-31 | 114,427,104 |
Total employer contributions | 2018-12-31 | 10,794,901 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2018-12-31 | 10,690,026 |
Minimum required contributions for current year target normal cost | 2018-12-31 | 14,550,069 |
Total funding amount beforereflecting carryover/prefunding balances | 2018-12-31 | 14,550,069 |
Carryover balance elected to use to offset funding requirement | 2018-12-31 | 3,860,043 |
Additional cash requirement | 2018-12-31 | 10,690,026 |
Contributions allocatedtoward minimum required contributions for current year | 2018-12-31 | 10,690,026 |
Total participants, beginning-of-year | 2018-01-01 | 11,772 |
Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 8,056 |
Number of retired or separated participants receiving benefits | 2018-01-01 | 51 |
Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 3,536 |
Total of all active and inactive participants | 2018-01-01 | 11,643 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2018-01-01 | 30 |
Total participants | 2018-01-01 | 11,673 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2018-01-01 | 348 |
2017: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2017 401k membership | ||
Market value of plan assets | 2017-12-31 | 362,916,479 |
Acturial value of plan assets | 2017-12-31 | 371,820,518 |
Funding target for retired participants and beneficiaries receiving payment | 2017-12-31 | 32,499,764 |
Number of terminated vested participants | 2017-12-31 | 2,967 |
Fundng target for terminated vested participants | 2017-12-31 | 42,180,492 |
Active participant vested funding target | 2017-12-31 | 210,786,211 |
Number of active participants | 2017-12-31 | 7,868 |
Total funding liabilities for active participants | 2017-12-31 | 212,787,544 |
Total participant count | 2017-12-31 | 11,258 |
Total funding target for all participants | 2017-12-31 | 287,467,800 |
Balance at beginning of prior year after applicable adjustments | 2017-12-31 | 100,639,493 |
Amount remaining of carryover balance | 2017-12-31 | 100,639,493 |
Balance of carryovers at beginning of current year | 2017-12-31 | 100,639,493 |
Total employer contributions | 2017-12-31 | 17,424,361 |
Contributions allocated toward minimum required contributions for current year adjusted to valuation date | 2017-12-31 | 17,077,565 |
Minimum required contributions for current year target normal cost | 2017-12-31 | 13,640,393 |
Total funding amount beforereflecting carryover/prefunding balances | 2017-12-31 | 13,640,393 |
Additional cash requirement | 2017-12-31 | 13,640,393 |
Contributions allocatedtoward minimum required contributions for current year | 2017-12-31 | 17,077,565 |
Total participants, beginning-of-year | 2017-01-01 | 11,258 |
Total number of active participants reported on line 7a of the Form 5500 | 2017-01-01 | 8,034 |
Number of retired or separated participants receiving benefits | 2017-01-01 | 425 |
Number of other retired or separated participants entitled to future benefits | 2017-01-01 | 3,173 |
Total of all active and inactive participants | 2017-01-01 | 11,632 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2017-01-01 | 58 |
Total participants | 2017-01-01 | 11,690 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2017-01-01 | 342 |
Measure | Date | Value |
---|---|---|
2022 : THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2022 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $-77,968,179 |
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $-77,968,179 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $218,988 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $355,386 |
Total income from all sources (including contributions) | 2022-12-31 | $-67,016,559 |
Total loss/gain on sale of assets | 2022-12-31 | $1,496,458 |
Total of all expenses incurred | 2022-12-31 | $33,816,019 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $31,401,648 |
Value of total assets at end of year | 2022-12-31 | $307,658,810 |
Value of total assets at beginning of year | 2022-12-31 | $408,627,786 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $2,414,371 |
Total interest from all sources | 2022-12-31 | $3,662,307 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $5,789,751 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $5,169,308 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $15,000,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $859,712 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $933,436 |
Other income not declared elsewhere | 2022-12-31 | $3,104 |
Administrative expenses (other) incurred | 2022-12-31 | $1,756,039 |
Liabilities. Value of operating payables at end of year | 2022-12-31 | $207,726 |
Liabilities. Value of operating payables at beginning of year | 2022-12-31 | $321,403 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-100,832,578 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $307,439,822 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $408,272,400 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2022-12-31 | $41,187,952 |
Assets. partnership/joint venture interests at beginning of year | 2022-12-31 | $45,139,278 |
Investment advisory and management fees | 2022-12-31 | $658,332 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $138,726,386 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $181,210,273 |
Value of interest in pooled separate accounts at end of year | 2022-12-31 | $0 |
Interest earned on other investments | 2022-12-31 | $3,553,185 |
Value of interest in common/collective trusts at end of year | 2022-12-31 | $15,306,666 |
Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $27,024,979 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $3,296,930 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $5,547,357 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $5,547,357 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $109,122 |
Asset value of US Government securities at end of year | 2022-12-31 | $11,639,515 |
Asset value of US Government securities at beginning of year | 2022-12-31 | $12,417,246 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Income. Dividends from common stock | 2022-12-31 | $620,443 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $31,401,648 |
Asset. Corporate debt instrument debt (other) at end of year | 2022-12-31 | $65,029,166 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-31 | $91,795,525 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $31,612,483 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $44,559,692 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Aggregate proceeds on sale of assets | 2022-12-31 | $157,297,953 |
Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $155,801,495 |
Liabilities. Value of acquisition indebtedness at end of year | 2022-12-31 | $11,262 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2022-12-31 | $33,983 |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | UHY LLP |
Accountancy firm EIN | 2022-12-31 | 200694403 |
2021 : THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2021 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $-8,766,947 |
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $-8,766,947 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $355,386 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $314,088 |
Total income from all sources (including contributions) | 2021-12-31 | $28,986,740 |
Total loss/gain on sale of assets | 2021-12-31 | $26,078,536 |
Total of all expenses incurred | 2021-12-31 | $32,984,144 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $30,210,742 |
Value of total assets at end of year | 2021-12-31 | $408,627,786 |
Value of total assets at beginning of year | 2021-12-31 | $412,583,892 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $2,773,402 |
Total interest from all sources | 2021-12-31 | $5,564,991 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $6,108,493 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $5,550,206 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $15,000,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $933,436 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $900,589 |
Other income not declared elsewhere | 2021-12-31 | $1,667 |
Administrative expenses (other) incurred | 2021-12-31 | $1,784,900 |
Liabilities. Value of operating payables at end of year | 2021-12-31 | $321,403 |
Liabilities. Value of operating payables at beginning of year | 2021-12-31 | $313,122 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $-3,997,404 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $408,272,400 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $412,269,804 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2021-12-31 | $45,139,278 |
Assets. partnership/joint venture interests at beginning of year | 2021-12-31 | $43,336,599 |
Investment advisory and management fees | 2021-12-31 | $988,502 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $181,210,273 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $141,078,875 |
Value of interest in pooled separate accounts at end of year | 2021-12-31 | $0 |
Interest earned on other investments | 2021-12-31 | $5,540,230 |
Value of interest in common/collective trusts at end of year | 2021-12-31 | $27,024,979 |
Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $47,464,441 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $5,547,357 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $28,282,646 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $28,282,646 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $24,761 |
Asset value of US Government securities at end of year | 2021-12-31 | $12,417,246 |
Asset value of US Government securities at beginning of year | 2021-12-31 | $11,420,822 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Income. Dividends from common stock | 2021-12-31 | $558,287 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $30,210,742 |
Asset. Corporate debt instrument debt (other) at end of year | 2021-12-31 | $91,795,525 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2021-12-31 | $94,211,880 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2021-12-31 | $44,559,692 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-12-31 | $45,888,040 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Aggregate proceeds on sale of assets | 2021-12-31 | $202,716,411 |
Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $176,637,875 |
Liabilities. Value of acquisition indebtedness at end of year | 2021-12-31 | $33,983 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2021-12-31 | $966 |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | UHY LLP |
Accountancy firm EIN | 2021-12-31 | 200694403 |
2020 : THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2020 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $22,737,644 |
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $22,737,644 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $314,088 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $259,224 |
Total income from all sources (including contributions) | 2020-12-31 | $63,568,589 |
Total loss/gain on sale of assets | 2020-12-31 | $10,167,941 |
Total of all expenses incurred | 2020-12-31 | $30,937,239 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $28,471,989 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $21,375,000 |
Value of total assets at end of year | 2020-12-31 | $412,583,892 |
Value of total assets at beginning of year | 2020-12-31 | $379,897,678 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $2,465,250 |
Total interest from all sources | 2020-12-31 | $5,436,120 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $3,846,105 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $3,388,616 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $10,000,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $900,589 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $1,040,248 |
Other income not declared elsewhere | 2020-12-31 | $5,779 |
Administrative expenses (other) incurred | 2020-12-31 | $1,643,775 |
Liabilities. Value of operating payables at end of year | 2020-12-31 | $313,122 |
Liabilities. Value of operating payables at beginning of year | 2020-12-31 | $249,524 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $32,631,350 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $412,269,804 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $379,638,454 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2020-12-31 | $43,336,599 |
Assets. partnership/joint venture interests at beginning of year | 2020-12-31 | $71,437,150 |
Investment advisory and management fees | 2020-12-31 | $821,475 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $141,078,875 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $108,813,485 |
Value of interest in pooled separate accounts at end of year | 2020-12-31 | $0 |
Interest earned on other investments | 2020-12-31 | $5,398,981 |
Value of interest in common/collective trusts at end of year | 2020-12-31 | $47,464,441 |
Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $35,664,681 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $28,282,646 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $20,902,331 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $20,902,331 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $37,139 |
Asset value of US Government securities at end of year | 2020-12-31 | $11,420,822 |
Asset value of US Government securities at beginning of year | 2020-12-31 | $9,656,633 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $21,375,000 |
Employer contributions (assets) at beginning of year | 2020-12-31 | $2,375,000 |
Income. Dividends from common stock | 2020-12-31 | $457,489 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $28,471,989 |
Asset. Corporate debt instrument debt (other) at end of year | 2020-12-31 | $94,211,880 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2020-12-31 | $95,139,017 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $45,888,040 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $34,869,133 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Aggregate proceeds on sale of assets | 2020-12-31 | $315,256,706 |
Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $305,088,765 |
Liabilities. Value of acquisition indebtedness at end of year | 2020-12-31 | $966 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2020-12-31 | $9,700 |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Disclaimer |
Accountancy firm name | 2020-12-31 | GRANT THORNTON |
Accountancy firm EIN | 2020-12-31 | 366055558 |
2019 : THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2019 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $36,270,262 |
Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $36,270,262 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $36,270,262 |
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $36,270,262 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $259,224 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $259,224 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $337,413 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $337,413 |
Total income from all sources (including contributions) | 2019-12-31 | $65,527,498 |
Total income from all sources (including contributions) | 2019-12-31 | $65,527,498 |
Total loss/gain on sale of assets | 2019-12-31 | $12,462,101 |
Total loss/gain on sale of assets | 2019-12-31 | $12,462,101 |
Total of all expenses incurred | 2019-12-31 | $19,341,389 |
Total of all expenses incurred | 2019-12-31 | $19,341,389 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $16,998,978 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $16,998,978 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $8,375,000 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $8,375,000 |
Value of total assets at end of year | 2019-12-31 | $379,897,678 |
Value of total assets at end of year | 2019-12-31 | $379,897,678 |
Value of total assets at beginning of year | 2019-12-31 | $333,789,758 |
Value of total assets at beginning of year | 2019-12-31 | $333,789,758 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $2,342,411 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $2,342,411 |
Total interest from all sources | 2019-12-31 | $5,525,590 |
Total interest from all sources | 2019-12-31 | $5,525,590 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $2,454,613 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $2,454,613 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $10,000,000 |
Value of fidelity bond cover | 2019-12-31 | $10,000,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $9,779,594 |
Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $9,779,594 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $1,040,248 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $1,040,248 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $1,271,983 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $1,271,983 |
Other income not declared elsewhere | 2019-12-31 | $439,932 |
Other income not declared elsewhere | 2019-12-31 | $439,932 |
Administrative expenses (other) incurred | 2019-12-31 | $1,435,162 |
Administrative expenses (other) incurred | 2019-12-31 | $1,435,162 |
Liabilities. Value of operating payables at end of year | 2019-12-31 | $249,524 |
Liabilities. Value of operating payables at beginning of year | 2019-12-31 | $319,764 |
Liabilities. Value of operating payables at beginning of year | 2019-12-31 | $319,764 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $46,186,109 |
Value of net income/loss | 2019-12-31 | $46,186,109 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $379,638,454 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $379,638,454 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $333,452,345 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $333,452,345 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2019-12-31 | $71,437,150 |
Assets. partnership/joint venture interests at end of year | 2019-12-31 | $71,437,150 |
Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $67,148,054 |
Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $67,148,054 |
Investment advisory and management fees | 2019-12-31 | $907,249 |
Investment advisory and management fees | 2019-12-31 | $907,249 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $108,813,485 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $108,813,485 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $77,923,948 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $77,923,948 |
Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
Interest earned on other investments | 2019-12-31 | $5,398,553 |
Interest earned on other investments | 2019-12-31 | $5,398,553 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $35,664,681 |
Value of interest in common/collective trusts at end of year | 2019-12-31 | $35,664,681 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $31,216,469 |
Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $31,216,469 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $20,902,331 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $20,902,331 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $6,028,505 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $6,028,505 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $6,028,505 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $6,028,505 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $127,037 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $127,037 |
Asset value of US Government securities at end of year | 2019-12-31 | $9,656,633 |
Asset value of US Government securities at end of year | 2019-12-31 | $9,656,633 |
Asset value of US Government securities at beginning of year | 2019-12-31 | $5,335,955 |
Asset value of US Government securities at beginning of year | 2019-12-31 | $5,335,955 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | Yes |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $8,375,000 |
Contributions received in cash from employer | 2019-12-31 | $8,375,000 |
Employer contributions (assets) at end of year | 2019-12-31 | $2,375,000 |
Employer contributions (assets) at end of year | 2019-12-31 | $2,375,000 |
Income. Dividends from common stock | 2019-12-31 | $2,454,613 |
Income. Dividends from common stock | 2019-12-31 | $2,454,613 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $16,998,978 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $16,998,978 |
Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $95,139,017 |
Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $95,139,017 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $108,556,451 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $108,556,451 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $34,869,133 |
Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $34,869,133 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $26,528,799 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $26,528,799 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Aggregate proceeds on sale of assets | 2019-12-31 | $186,121,845 |
Aggregate proceeds on sale of assets | 2019-12-31 | $186,121,845 |
Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $173,659,744 |
Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $173,659,744 |
Liabilities. Value of acquisition indebtedness at end of year | 2019-12-31 | $9,700 |
Liabilities. Value of acquisition indebtedness at end of year | 2019-12-31 | $9,700 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2019-12-31 | $17,649 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2019-12-31 | $17,649 |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
Accountancy firm name | 2019-12-31 | GRANT THORNTON |
Accountancy firm name | 2019-12-31 | GRANT THORNTON |
Accountancy firm EIN | 2019-12-31 | 366055558 |
Accountancy firm EIN | 2019-12-31 | 366055558 |
2018 : THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2018 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2018-12-31 | $-28,416,428 |
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $-28,416,428 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $337,413 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $322,954 |
Total income from all sources (including contributions) | 2018-12-31 | $-2,248,188 |
Total loss/gain on sale of assets | 2018-12-31 | $5,618,303 |
Total of all expenses incurred | 2018-12-31 | $73,777,637 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $71,411,131 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $10,794,901 |
Value of total assets at end of year | 2018-12-31 | $333,789,758 |
Value of total assets at beginning of year | 2018-12-31 | $409,801,124 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $2,366,506 |
Total interest from all sources | 2018-12-31 | $6,918,999 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $2,481,752 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Administrative expenses professional fees incurred | 2018-12-31 | $293,632 |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $10,000,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2018-12-31 | $9,779,594 |
Assets. Other investments not covered elsewhere at beginning of year | 2018-12-31 | $11,174,558 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2018-12-31 | $1,271,983 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2018-12-31 | $1,405,386 |
Other income not declared elsewhere | 2018-12-31 | $354,285 |
Administrative expenses (other) incurred | 2018-12-31 | $1,033,843 |
Liabilities. Value of operating payables at end of year | 2018-12-31 | $319,764 |
Liabilities. Value of operating payables at beginning of year | 2018-12-31 | $321,554 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $-76,025,825 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $333,452,345 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $409,478,170 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2018-12-31 | $67,148,054 |
Assets. partnership/joint venture interests at beginning of year | 2018-12-31 | $75,466,793 |
Investment advisory and management fees | 2018-12-31 | $1,039,031 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $77,923,948 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $92,084,967 |
Value of interest in pooled separate accounts at end of year | 2018-12-31 | $0 |
Interest earned on other investments | 2018-12-31 | $6,769,554 |
Value of interest in common/collective trusts at end of year | 2018-12-31 | $31,216,469 |
Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $43,356,064 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-12-31 | $6,028,505 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-12-31 | $8,512,477 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-12-31 | $8,512,477 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2018-12-31 | $149,445 |
Asset value of US Government securities at end of year | 2018-12-31 | $5,335,955 |
Asset value of US Government securities at beginning of year | 2018-12-31 | $17,237,891 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $10,794,901 |
Income. Dividends from common stock | 2018-12-31 | $2,481,752 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $71,411,131 |
Asset. Corporate debt instrument debt (other) at end of year | 2018-12-31 | $108,556,451 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2018-12-31 | $127,400,640 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2018-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2018-12-31 | $26,528,799 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2018-12-31 | $33,162,348 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Aggregate proceeds on sale of assets | 2018-12-31 | $245,520,722 |
Aggregate carrying amount (costs) on sale of assets | 2018-12-31 | $239,902,419 |
Liabilities. Value of acquisition indebtedness at end of year | 2018-12-31 | $17,649 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2018-12-31 | $1,400 |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
Accountancy firm name | 2018-12-31 | GRANT THORNTON |
Accountancy firm EIN | 2018-12-31 | 366055558 |
2017 : THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2017 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2017-12-31 | $1,074,042 |
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $1,074,042 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $322,954 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $1,115,514 |
Total income from all sources (including contributions) | 2017-12-31 | $68,457,904 |
Total loss/gain on sale of assets | 2017-12-31 | $40,026,533 |
Total of all expenses incurred | 2017-12-31 | $20,852,449 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $18,534,352 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $17,424,361 |
Value of total assets at end of year | 2017-12-31 | $409,801,124 |
Value of total assets at beginning of year | 2017-12-31 | $362,988,229 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $2,318,097 |
Total interest from all sources | 2017-12-31 | $6,736,618 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $3,192,913 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Administrative expenses professional fees incurred | 2017-12-31 | $279,600 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $10,000,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Assets. Other investments not covered elsewhere at end of year | 2017-12-31 | $11,174,558 |
Assets. Other investments not covered elsewhere at beginning of year | 2017-12-31 | $13,978,881 |
Value of other receiveables (less allowance for doubtful accounts) at end of year | 2017-12-31 | $1,405,386 |
Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2017-12-31 | $551,448 |
Other income not declared elsewhere | 2017-12-31 | $3,437 |
Administrative expenses (other) incurred | 2017-12-31 | $910,011 |
Liabilities. Value of operating payables at end of year | 2017-12-31 | $321,554 |
Liabilities. Value of operating payables at beginning of year | 2017-12-31 | $1,043,765 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $47,605,455 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $409,478,170 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $361,872,715 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Assets. partnership/joint venture interests at end of year | 2017-12-31 | $75,466,793 |
Assets. partnership/joint venture interests at beginning of year | 2017-12-31 | $70,398,500 |
Investment advisory and management fees | 2017-12-31 | $1,128,486 |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $92,084,967 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $82,153,577 |
Interest earned on other investments | 2017-12-31 | $6,674,083 |
Value of interest in common/collective trusts at end of year | 2017-12-31 | $43,356,064 |
Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $73,488,768 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2017-12-31 | $8,512,477 |
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2017-12-31 | $3,074,270 |
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2017-12-31 | $3,074,270 |
Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2017-12-31 | $62,535 |
Asset value of US Government securities at end of year | 2017-12-31 | $17,237,891 |
Asset value of US Government securities at beginning of year | 2017-12-31 | $35,363,272 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | Yes |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $17,424,361 |
Income. Dividends from common stock | 2017-12-31 | $3,192,913 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $18,534,352 |
Asset. Corporate debt instrument debt (other) at end of year | 2017-12-31 | $127,400,640 |
Asset. Corporate debt instrument debt (other) at beginning of year | 2017-12-31 | $42,434,625 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2017-12-31 | No |
Assets. Corporate common stocks other than exployer securities at end of year | 2017-12-31 | $33,162,348 |
Assets. Corporate common stocks other than exployer securities at beginning of year | 2017-12-31 | $41,544,888 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Aggregate proceeds on sale of assets | 2017-12-31 | $414,312,418 |
Aggregate carrying amount (costs) on sale of assets | 2017-12-31 | $374,285,885 |
Liabilities. Value of acquisition indebtedness at end of year | 2017-12-31 | $1,400 |
Liabilities. Value of acquisition indebtedness at beginning of year | 2017-12-31 | $71,749 |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
Accountancy firm name | 2017-12-31 | KPMG LLP |
Accountancy firm EIN | 2017-12-31 | 135565207 |
2022: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2022 form 5500 responses | ||
---|---|---|
2022-01-01 | Type of plan entity | Single employer plan |
2022-01-01 | Plan funding arrangement – Trust | Yes |
2022-01-01 | Plan benefit arrangement - Trust | Yes |
2021: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2021 form 5500 responses | ||
2021-01-01 | Type of plan entity | Single employer plan |
2021-01-01 | Plan funding arrangement – Trust | Yes |
2021-01-01 | Plan benefit arrangement - Trust | Yes |
2020: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | Single employer plan |
2020-01-01 | Plan funding arrangement – Trust | Yes |
2020-01-01 | Plan benefit arrangement - Trust | Yes |
2019: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2019 form 5500 responses | ||
2019-01-01 | Type of plan entity | Single employer plan |
2019-01-01 | Plan funding arrangement – Trust | Yes |
2019-01-01 | Plan benefit arrangement - Trust | Yes |
2018: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2018 form 5500 responses | ||
2018-01-01 | Type of plan entity | Single employer plan |
2018-01-01 | Plan funding arrangement – Trust | Yes |
2018-01-01 | Plan benefit arrangement - Trust | Yes |
2017: THE ALBANY MEDICAL CENTER RETIREMENT PLAN 2017 form 5500 responses | ||
2017-01-01 | Type of plan entity | Single employer plan |
2017-01-01 | Plan funding arrangement – Trust | Yes |
2017-01-01 | Plan benefit arrangement - Trust | Yes |